SynthesisFrontiers in public health2023

Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review.

Makoto Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.